Our strategy is to develop first-in-class therapeutics for horses by leveraging the science and validated compounds and targets from human pharmaceuticals.
We have a pipeline with drugs and biologics in development that are made to meet the needs of the horse, the owner, the trainer, and the veterinarian.
SAFETY AND REGULATION
There is a tremendous amount of effort behind every safe, effective, and successful therapy. It begins with carefully planned clinical trials and testing.
VETERINARY THERAPEUTICS. REDEFINED.
As one of the first veterinary biotech companies in the world, we understood early that, to quickly deliver veterinary therapeutics in unmet and underserved areas, we needed a revolutionary approach. By leveraging the similarities between human and horse diseases, we are creating cutting-edge versions of successful human drugs and biologics. Our belief is that this can substantially increase success rate and reduce time to market – increasing the quality of life for the horse companions with whom we share so much of our lives, providing the veterinary community with innovative treatment options, and, we anticipate, generating solid returns for our investors.
KindredBio was founded
KindredBio went public
KindredBio Equine was founded
REASONS TO LOVE HORSES